20086 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction; Excipients; Inactive ingredients; Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
Nanoparticles For Crossing The Blood Brain Barrier And Methods Of Treatment Using The Same
#302METHOD FOR THE PRODUCTION OF PRECISELY SIZED MACRO- AND MICRO-ELP CONTAINING PARTICLES FOR THE DELIVERY OF THERAPEUTIC AGENTS
#303Poly(ketals) and related compositions and methods
#304Medical treatment comprising enteral administration of edaravone
#305CHEMICAL COMPOSITION
#306SUSTAINED DELIVERY OF THERAPEUTIC AGENTS TO AN EYE COMPARTMENT
#307Complexes of Celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#30817-hydroxyprogesterone ester-containing oral compositions and related methods
#309PACA and cabazitaxel for anti-cancer treatment
#310Pharmaceutical compositions
#311PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN
#312Pharmaceutical compositions
#313Pharmaceutical compositions
#314MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
#315Macroporous chitosan-polyacrylamide hydrogel microspheres and preparation thereof
#316Tamper-resistant pharmaceutical compositions of opioids and other drugs
#317Formulations of 6-(2-hydroxy-2-methylpropxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-A]pyridine-3-carbonitrile
#318Crosslinked particles
#319Pharmaceutical compositions
#320Hydrogel encapsulated cells and anti-inflammatory drugs
#321Compositions comprising PGI2-receptor agonists and processes for the preparation thereof
#322NANOPARTICLE DIAGNOSTIC AND METHODS FOR TREATING DISEASE
#323Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#324Particulate formulations for enhancing growth in animals
#325Stable formulations of linaclotide
#326Device and kit for dosing and dispensing non-liquid medicine
#327PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING
#328DRUG DELIVERY SYSTEMS AND TARGETED RELEASE OF PHARMACEUTICAL AGENTS WITH FOCUSED ULTRASOUND
#329Amorphous solid dispersions
#330COMPOSITIONS INCLUDING ENCAPSULATED ISOTRETINOIN AND METHODS FOR USE THEREOF
#331ONE STEP MILLING PROCESS FOR PREPARING MICRONIZED PALIPERIDONE ESTERS
#332Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#333Abuse resistant pharmaceutical compositions
#334TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#335Pharmaceutical composition containing celecoxib
#336System and Method for Multiphasic Release of Growth Factors
#337Pharmaceutical formulation containing gelling agent
#338TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#339Pharmaceutical Formulation Containing Gelling Agent
#340Solid Nanoparticle Formulation of Water Insoluble Pharmaceutical Substances with Reduced Ostwald Ripening
#341Composition comprising fine particle and process thereof
#342Pharmaceutical compositions of pimobendan
#343Pharmaceutical compositions of pimobendan
#344Freeze dried drug nanosuspensions
#345Pharmaceutical compositions
#346Pharmaceutical formulation containing gelling agent
#347Pharmaceutical compositions
#348Powder for oral suspension containing lamotrigine
#349TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#350Methods, compositions, and devices for drug/live cell microarrays
#351A UNIQUE HIGH-SHEAR GRANULATION PROCESS FOR IMPROVED BIOAVAILABILITY OF RIVAROXABAN
#352Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#353POLYPEPTIDES, ANTIBODY VARIABLE DOMAINS & ANTAGONISTS
#354Method, composition and package for bowel cleansing
#355Compositions, methods and devices for forming gel implants from injected liquids
#356Compounds and compositions for intracellular delivery of therapeutic agents
#357Pharmaceutical compositions comprising phenylaminopyrimidine derivative
#358Pharmaceutical Formulation Containing Gelling Agent
#359Multifunctional Metal Nanoparticles Having a Polydopamine-Based Surface and Methods of Making and Using the Same
#360Use of dihydroxyacetone in preparation of anti-cancer medicaments
#361TAMPER RESISTANT DOSAGE FORMS
#362Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#363TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#364ENHANCED THERAPEUTIC USAGE OF A PURINE NUCLEOSIDE PHOSPHORYLASE OR NUCLEOSIDE HYDROLASE PRODRUG
#365FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES
#366Corticosteroids for the treatment of joint pain
#367Device and kit for dosing and dispensing non-liquid medicine
#368An Oral Preparation for the Treatment of Cardiovascular Disease and Its Preparation Method
#369METHOD OF MAKING DIALKYL SULFOSUCCINATE COMPOSITIONS
#37017-HYDROXYPROGESTERONE ESTER-CONTAINING ORAL COMPOSITIONS AND RELATED METHODS
#371Compounds and compositions for intracellular delivery of therapeutic agents
#372DULOXETINE SPRINKLES
#373Novel formulation of metaxalone
#374Microbiota restoration therapy (MRT) compositions and methods of manufacture
#375METHOD FOR TREATING INTESTINAL FIBROSIS
#376Gastro-resistant formulation containing posaconazole
#377Modified release compositions comprising tacrolimus
#378Anti-malaria compositions and methods
#379LONG ACTING LIRAGLUTIDE COMPOSITIONS
#380Solid dispersions comprising tacrolimus
#381Compounds and compositions for intracellular delivery of therapeutic agents
#382Drug compositions
#383ANHYDROUS CRYSTALLINE FREE BASE FORM OF 6-{2-[1-(6-METHYL-3-PYRIDAZINYL)-4-PIPERIDINYL]ETHOXY}-3-ETHOXY-1,2-BENZISOXAZOLE
#384FORMATION OF CYCLOSPORIN A/CYCLODEXTRIN NANOPARTICLES
#385Duloxetine sprinkles
#386Sustained delivery of therapeutic agents to an eye compartment
#387Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#388Tamper resistant dosage forms
#389Tamper resistant dosage forms
#390Pharmaceutical Formulation Containing Gelling Agent
#391Nicotinamide compositions and the therapeutic use thereof
#392Pharmaceutical Formulation Containing Gelling Agent
#393POWDER COATING COMPOSITIONS FOR COATING PHARMACEUTICAL PELLETS
#394PHARMACEUTICAL COMPOSITIONS WITH SYNCHRONIZED SOLUBILIZER RELEASE
#395Hydrogel encapsulated cells and anti-inflammatory drugs
#396Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
#397TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#398GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
#399Solid pharmaceutical formulation of PARP inhibitors and use thereof
#400Bendamustine pharmaceutical compositions
#401Soluble microneedle for delivering poorly-soluble drug
#402Naltrexone Long Acting Formulations and Methods of Use
#403THERAPEUTIC NANOPARTICLES AND METHODS THEREOF
#404Pharmaceutical formulation containing gelling agent
#405Hydrobromide salt of an anti-HIV compound
#406Pharmaceutical compositions
#407Drug compositions comprising an anti-parasitic and proton pump inhibitor
#408Pharmaceutical compositions of goserelin sustained release microspheres
#409Pharmaceutical formulation containing gelling agent
#410Nanoemulsions
#411Novel formulation of metaxalone
#412Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
#413Compositions, methods and devices for forming implants from injected liquids
#414Carrier-free nanoparticles
#415TAMPER RESISTANT DOSAGE FORMS
#416TAMPER RESISTANT DOSAGE FORMS
#417TAMPER RESISTANT DOSAGE FORMS
#418System and Method for Multiphasic Release of Growth Factors
#419FORMULATIONS OF RIFAXIMIN AND USES THEREOF
#420Pharmaceutical composition comprising dabigatran etexilate, and preparation method, solid preparation and use thereof
#421Sustained Release Formulation and Use Thereof
#422Abuse resistant pharmaceutical compositions
#423Tamper-resistant pharmaceutical compositions of opioids and other drugs
#424TAMPER RESISTANT DOSAGE FORMS
#425TAMPER RESISTANT DOSAGE FORMS
#426TAMPER RESISTANT DOSAGE FORMS
#427TAMPER RESISTANT DOSAGE FORMS
#428TAMPER RESISTANT DOSAGE FORMS
#429TAMPER RESISTANT DOSAGE FORMS
#430TAMPER RESISTANT DOSAGE FORMS
#431TAMPER RESISTANT DOSAGE FORMS
#432TAMPER RESISTANT DOSAGE FORMS
#433TAMPER RESISTANT DOSAGE FORMS
#434TAMPER RESISTANT DOSAGE FORMS
#435Twin-screw dry granulation for producing solid formulations
#436MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
#437PHARMACEUTICAL PREPARATION AND METHOD OF ITS PRODUCTION AND USE
#438Pharmaceutical combination composition comprising complex formulations of Ivacaftor and Lumacaftor and their salts and derivatives, process for their preparation thereof and pharmaceutical compositions containing them
#439Extended release, abuse deterrent dosage forms
#440Compositions for stabilizing and delivering proteins
#441System and Method for Multiphasic Release of Growth Factors
#442PALATABLE COMPOSITIONS INCLUDING SODIUM PHENYLBUTYRATE AND USES THEREOF
#443Virus-PCION complex having enhanced antitumor effect by using electromagnetic field
#444Injectable neurosteroid formulations containing nanoparticles
#445Compounds and compositions for intracellular delivery of therapeutic agents
#446Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
#447MULTIFUNCTIONAL POLYMERIC NANOPARTICLE FOR DIAGNOSIS OR TREATMENT OF CEREBRAL DISEASES AND A PREPARATION METHOD THEREOF
#448DOSAGE FORMS OF APIXABAN
#449Biomarker specific amphiphilic nanoparticles
#450Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#451Compositions for providing agents that degrade in water
#452Corticosteroids for the treatment of joint pain
#453Amorphous onapristone compositions and methods of making the same
#454LIQUID FORMULATION COMPOSITIONS, MEDICAMENT DELIVERY DEVICES, AND METHODS OF PREPARATION AND USE THEREOF
#455Polymer protein microparticles
#456Polypeptides, antibody variable domains and antagonists
#457Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
#458pH-responsive mucoadhesive polymeric encapsulated microorganisms
#459Microneedle-based transdermal delivery system and method of making same
#460Pharmaceutical compositions
#461Pharmaceutical compositions
#462NANOPARTICULATE FORMULATION COMPRISING A mPGES-1 INHIBITOR
#463PHARMACEUTICAL COMPOSITIONS COMPRISING A 5,5-FUSED HETEROARYLENE FLAVIVIRIDAE INHIBITOR AND THEIR USE FOR TREATING OR PREVENTING FLAVIVIRIDAE INFECTION
#464Aggregating microparticles for medical therapy
#465OCULAR TREATMENT WITH REDUCED INTRAOCULAR PRESSURE
#466Lipid particles and nucleic acid delivery carrier
#467THERAPEUTIC NANOPARTICLES AND METHODS THEREOF
#468PHARMACEUTICAL COMPOSITIONS FOR TRANSMUCOSAL DELIVERY
#469SUSPENSION AND CAKE COMPOSITION CONTAINING CARBOSTYRYL DERIVATIVE AND SILICONE OIL AND/OR SILICONE OIL DERIVATIVE
#470TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#471Pharmaceutical formulation containing gelling agent
#472Freeze-dried powder of high molecular weight silk fibroin, preparation method therefor and use thereof
#473RNAi PHARMACEUTICAL COMPOSITION FOR SUPPRESSING EXPRESSION OF CKAP5 GENE
#474Crosslinked particles
#475Process for drying of BIBW2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
#476Particulate formulations for improving feed conversion rate in a subject
#477Protecting oral overdose with abuse deterrent immediate release formulations
#478Tamper resistant dosage forms
#479Pharmaceutical formulation containing gelling agent
#480MICRO/NANO COMPOSITE DRUG DELIVERY FORMULATIONS AND USES THEREOF
#481Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
#482FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS
#483NANOPARTICLES FOR TARGETED GENE THERAPY AND METHODS OF USE THEREOF
#484LUNG TARGETING DUAL DRUG DELIVERY SYSTEM
#485Composition of analgesic bioadhesive healing microspheres
#486Pharmaceutical formulation containing gelling agent
#487Pharmaceutical formulation containing gelling agent
#488SOLID DISPERSION OF INDIRUBIN
#489OCULAR TREATMENT WITH REDUCED INTRAOCULAR PRESSURE
#490COMPOSITIONS AND METHODS RELATING TO REDUCED MUCOADHESION
#491Pharmaceutical composition with improved bioavailability
#492Method of treating non-small-cell lung cancer using pharmaceutical formulation containing thienotriazolodiazepine compounds
#493LEPTIN mRNA COMPOSITIONS AND FORMULATIONS
#494Pharmaceutical compositions
#495NOVEL PROCESS FOR PRODUCING TRANSMUCOSAL PHARMACEUTICAL FORMULATIONS AND FORMULATIONS THUS OBTAINED
#496PHARMACEUTICAL COMPOSITION OF SELECTIVE HCV NS3/4A INHIBITORS
#497Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#498Freeze dried drug nanosuspensions
#499Composition comprising tetracyclic compound
#500Dialkyl sulfosuccinate compositions, method of making, and method of use
#501Tamper-resistant dosage form with immediate release and resistance against solvent extraction
#502TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION
#503TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM DIFFERENT PARTICLES
#504TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM PARTICLES AND A POWDER
#505Solid pharmaceutical and vaccine dose
#506Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
#507Abuse resistant pharmaceutical compositions
#508DRYING TECHNIQUES FOR MICROFLUIDIC AND OTHER SYSTEMS
#509Pharmaceutical preparation and method of its production and use
#510Fabrication of hydrogel microsphere delivery vehicles through electrospraying and timed gelation
#511Formulations of single domain antigen binding molecules
#512Process for the preparation of a freeze-dried pharmaceutical composition containing mitomycin C
#513FILM DELIVERY SYSTEM FOR ACTIVE INGREDIENTS
#514Method, composition and package for bowel cleansing
#515Tacrolimus for improved treatment of transplant patients
#516Modified release compositions comprising tacrolimus
#517Compositions, methods and devices for local drug delivery
#518METHOD OF CONVERTING A CRYSTALLINE COMPOUND TO AN AMORPHOUS COMPOUND, METHOD OF INCREASING THE SOLUBILITY OF A CRYSTALLINE COMPOUND IN A BIORELEVANT FLUID, AND NANOPARTICLES THAT ACHIEVE SUPERSATURATION
#519Sustained delivery of therapeutic agents to an eye compartment
#520Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same
#521Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them
#522Selective production method for D-mannitol α-form crystal using spray-drying method
#523COMPOSITIONS COMPRISING LIPOPHILIC ACTIVE COMPOUNDS AND METHOD FOR THEIR PREPARATION
#524Novel Delivery Compositions and Methods of Using Same
#52517-hydroxyprogesterone ester-containing oral compositions and related methods
#526SOLID DISPERSION OF A SELECTIVE MODULATOR OF THE PROGESTERONE RECEPTOR
#527Compositions of 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
#528Method for treating intestinal fibrosis
#529Anhydrous crystalline free base form of 6-{2-[1 -(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole
#530Methods for treating edema in the eye and intraocular implants for use therefor
#531Reducing or non-reducing polynucleotide polymer for drug delivery and method for preparing same
#532MELT-PROCESSED POLYMERIC CELLULAR DOSAGE FORM
#533Continuous release compositions made from hyaluronic acid, and therapeutic applications of same
#534PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#535Reactive oxygen species (ROS)-responsive compositions and methods thereof
#536Nanoparticle Diagnostic and Methods for Treating Disease
#537Solid dispersions comprising tacrolimus
#538Pharmaceutical formulation containing gelling agent
#539Pharmaceutical formulation containing gelling agent
#540Pharmaceutical formulation containing gelling agent
#541Pharmaceutical formulation containing gelling agent
#542Pharmaceutical formulation containing gelling agent
#543Pharmaceutical formulation containing gelling agent
#544Pharmaceutical formulation containing gelling agent
#545Pharmaceutical formulation containing gelling agent
#546Microspheres of pancreatic enzymes with high stability and production method thereof
#547PHARMACEUTICAL COMPOSITIONS FOR INTRAOCULAR ADMINISTRATION AND METHODS FOR FABRICATING THEREOF
#548Hot-melt extrusion of modified release multi-particulates
#549Abuse resistant pharmaceutical compositions
#550Abuse resistant pharmaceutical compositions
#551Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#552PHARMACEUTICAL FORMULATION CONTAINING GELLING AGENT
#553Methods of treating proliferative diseases
#554Controlled release antimicrobial compositions and methods for the treatment of otic disorders
#555LONG CIRCULATING NANOPARTICLES FOR SUSTAINED RELEASE OF THERAPEUTIC AGENTS
#556Immunogenic composition
#557NANOPARTICLE FABRICATION METHODS, SYSTEMS, AND MATERIALS
#558SUSTAINED-RELEASE NANOPARTICLE COMPOSITIONS AND METHODS FOR USING THE SAME
#559ENCAPSULATED COMPOSITION FOR BINDING ALDEHYDES IN THE STOMACH
#560PHARMACEUTICAL COMPOSITIONS OF GOSERELIN SUSTAINED RELEASE MICROSPHERES
#561ORAL PHARMACEUTICAL COMPOSITIONS OF OSPEMIFENE
#562Pharmaceutical formulation containing gelling agent
#563Pharmaceutical Formulation Containing Gelling Agent
#564Pharmaceutical formulation containing gelling agent
#565Methods and compositions for bone formation
#566Multi-component particles for injection and processes for forming the same
#567Pharmaceutical compositions for gastrointestinal drug delivery
#568IN VIVO PHOTOACOUSTIC AND PHOTOTHERMAL NANO-THERANOSTICS OF BIOFILMS
#569Tamper resistant dosage forms
#570Tamper resistant dosage forms
#571Tamper resistant dosage forms
#572Tamper resistant dosage forms
#573Tamper resistant dosage forms
#574REHYDRATABLE PHARMACEUTICAL PRODUCT
#575OSSIFICATION-INDUCING COMPOSITIONS AND METHODS OF USE THEREOF
#57617-hydroxyprogesterone ester-containing oral compositions and related methods
#577Rehydratable pharmaceutical product
#578Nucleic acid lipid particle formulations
#579Core-shell particles, preparation process thereof, and composition containing the same
#580Pharmaceutical formulation containing gelling agent
#581Pharmaceutical Formulation Containing Gelling Agent
#582DOPA-melanin formation in high ionic strength solutions
#583Pharmaceutical formulation containing gelling agent
#584Pharmaceutical formulation containing gelling agent
#585Tamper resistant dosage forms
#586Tamper resistant dosage forms
#587Tamper resistant dosage forms
#588Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
#589Pharmaceutical formulation containing gelling agent
#590Spray drying vancomycin
#591Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
#592Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer
#593GASTRO-RETENTIVE DRUG DELIVERY SYSTEM
#594System and method for multiphasic release of growth factors
#595Amide compound
#596Pharmaceutical formulation containing gelling agent
#597Rufinamide solid dispersion
#598Sustained-release drug carrier composition
#599Dissolution enhanced controlled drug delivery system for poorly water soluble drugs
#60017-Hydroxyprogesterone ester containing oral compositions and related methods